Psykiatria
RECOVER trial suggests vagus nerve stimulation benefits some patients with severe treatment-resistant depression for at least two years
Raportoinut AI AI:n luoma kuva Faktatarkistettu
An implanted device that stimulates the vagus nerve was associated with sustained improvements in symptoms, functioning and quality of life among adults with long-standing, treatment-resistant major depression, according to researchers reporting two-year follow-up data from the ongoing RECOVER study led by Washington University School of Medicine in St. Louis.
Nainen raiskattiin väitetysti toisen potilaan toimesta suljetulla psykiatrisella osastolla Sundsvallin sairaalassa maanantai-iltapäivällä. Epäilty, 30-vuotias mies, otettiin kiinni paikan päällä ja pidätettiin oikeuden toimesta torstaina. Region Västernorrland vahvistaa vakavan tapauksen ja suunnittelee sisäistä tutkintaa.
Raportoinut AI Faktatarkistettu
A global genetics analysis has found extensive shared DNA risk across 14 psychiatric disorders, offering a clearer explanation for why many people receive multiple diagnoses over their lifetime. Using genomic data from more than six million individuals, researchers reported that the disorders cluster into five partially overlapping genetic groupings. The study was published Dec. 10, 2025, in Nature.
Tardive dyskinesia remains a significant side effect for patients on long-term antipsychotic medications. Recent medical discussions highlight its symptoms, causes, and emerging treatments. Awareness efforts aim to improve early detection and intervention.
Raportoinut AI
Magdeburg prosecutors are investigating Syrian psychiatrist Taleb al-Abdulmohsen for negligent manslaughter. A 54-year-old patient died shortly after discharge from a clinic in Brehna due to a medication overdose. The allegations stem from a criminal complaint filed by the deceased's relatives.